We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
+15.34%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.93M
AUM Growth
+$1.04M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 75.56%
2 Financials 23.95%
3 Miscellaneous 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
1
Traws Pharma
TRAW
$8.98M
$5.99M 75.56%
2,177
MMAC
2
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$1.9M 23.95%
72,552
ONTXW
3
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$39K 0.49%
390,624

Similar funds

Tyndall Capital Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Tyndall Capital Partners held 3 positions worth $7.93M, up 15% from $6.89M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. Tyndall Capital Partners opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 72% a quarter earlier, followed by Financials and Miscellaneous.

  • Tyndall Capital Partners's ten largest holdings make up 100% of its $7.93M portfolio in Q3 2018.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q3 2018.
  • Tyndall Capital Partners's portfolio value rose 15% quarter-over-quarter to $7.93M.

Based on Tyndall Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.